EP 2925329 B1 20210106 - USE OF POST-TRANSPLANT CYCLOPHOSPHAMIDE TREATED ALLOGENEIC MARROW INFILTRATING LYMPHOCYTES TO AUGMENT ANTI-TUMOR IMMUNITY
Title (en)
USE OF POST-TRANSPLANT CYCLOPHOSPHAMIDE TREATED ALLOGENEIC MARROW INFILTRATING LYMPHOCYTES TO AUGMENT ANTI-TUMOR IMMUNITY
Title (de)
VERWENDUNG VON AUF TRANSPLANTATIONEN FOLGENDEN CYCLOPHOSPHAMIDBEHANDELTEN ALLOGENEN KNOCHENMARKSINFILTRIERENDEN LYMPHOZYTEN ZUR STEIGERUNG DER ANTITUMORIMMUNITÄT
Title (fr)
UTILISATION DE LYMPHOCYTES INFILTRANT LA MOELLE ALLOGÉNIQUES TRAITÉS PAR CYCLOPHOSPHAMIDE POST-GREFFE POUR AUGMENTER L'IMMUNITÉ ANTI-TUMORALE
Publication
Application
Priority
- US 201261730239 P 20121127
- US 2013071975 W 20131126
IPC 8 full level
A61K 35/17 (2015.01); A61K 31/66 (2006.01); A61K 35/28 (2015.01); A61K 35/44 (2015.01); A61K 35/51 (2015.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/675 (2013.01 - EP US); A61K 35/17 (2013.01 - US); A61K 35/28 (2013.01 - EP US); A61K 35/51 (2013.01 - EP US); A61K 39/461 (2023.05 - EP); A61K 39/4621 (2023.05 - EP); A61K 39/46434 (2023.05 - EP); A61K 39/4644 (2023.05 - EP); A61P 35/00 (2017.12 - EP); A61K 2039/5158 (2013.01 - US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2014085437 A2 20140605; DK 2925329 T3 20210322; EP 2925329 A2 20151007; EP 2925329 A4 20160817; EP 2925329 B1 20210106; ES 2862433 T3 20211007; PT 2925329 T 20210329
DOCDB simple family (application)
US 2013071975 W 20131126; DK 13859049 T 20131126; EP 13859049 A 20131126; ES 13859049 T 20131126; PT 13859049 T 20131126